Delaware Valley Chapter Events

Practical and Value-added Statistics for the Non-statistician Session 2: Statistics for PPQ Accelerated timelines, complex supply chains, data constraints, evolving compliance requirements… These are just a few of the challenges of today’s...

Need a ride to INTERPHEX 2021 this year? Ditch the stress of NYC traffic & parking worries and come ride with the ISPE DVC crew to this year’s long-awaited INTERPHEX. Our comfortable private charter bus ride includes: Transportation to and from the...

Women in Pharma "Walk and Talk" Join fellow members of the ISPE Delaware Valley Chapter for our first “Walk and Talk” event at the historic Valley Forge National Park. Attendees will spend an hour or so walking the nearby trails at their pace, while...

Practical and Value-added Statistics for the Non-statistician Session 1: Using Design of Experiments (DOE) to define the process control strategy Accelerated timelines, complex supply chains, data constraints, evolving compliance requirements… These...

A program with a moderated panel discussion format that focuses on the evolving cell & gene therapy ecosystem in and around Philadelphia. The discussion will include how cell and gene therapy is different than traditional pharmaceutical manufacturing...

Integrated Approach to Semi-Continuous Biopharmaceutical Manufacturing GlaxoSmithKline’s approach to developing a semi-continuous manufacturing platform is to maximize equipment utilization and reduce the capital investment required for future...

Automation 101: An Introduction to Automation Automation has been and is increasingly now becoming a large part of the biopharmaceutical industry. From Delta V to Pharma 4.0, Automation and instrumentation terminology and technology can be difficult...

Capital Projects Supply Chain Impacts: Pre & Post Pandemic Covid has completely disrupted traditional supply chain systems across the world, including in the pharmaceutical industry. The industry has had to adapt and change to the new emerging world...

Assessing Environmental Impact of Biopharmaceutical Manufacturing Consistent with the overall industry trend to reduce environmental impact in manufacturing operations, GSK’s Biopharmaceutical Product Development and Supply team have implemented...

Supply Chain Part I: Active Pharmaceutical Ingredients (APIs) COVID has completely disrupted traditional supply chain systems across the world, including in the pharmaceutical industry. The industry has had to adapt and change to the new emerging...